Tumor necrosis factor receptor 1 signaling complex (TNFR1-SC)

The Tumor necrosis factor receptor 1 (TNFR1) signaling complex is a dynamic multi-protein assembly initiated by the binding of TNF-alpha to the TNFR1 receptor (UniProt P19438). It functions as a pivotal regulatory hub that dictates whether a cell undergoes pro-inflammatory survival or programmed cell death (Brenner et al., 2015). Upon activation, the complex initially forms 'Complex I' at the plasma membrane, recruiting proteins like TRADD, RIPK1, and TRAF2 to activate the NF-kappaB and MAPK pathways (Wajant et al., 2003). This primary signaling event promotes the expression of genes involved in inflammation and cell survival. However, if the complex is modified or internalized, it can transition into 'Complex II' or the necrosome, which triggers apoptosis or necroptosis via Caspase-8 or RIPK3/MLKL, respectively (Annibaldi & Meier, 2018). Dysfunctional TNFR1 signaling is central to the pathogenesis of chronic inflammatory diseases, such as rheumatoid arthritis and inflammatory bowel disease, and plays a role in cancer progression and neurodegeneration (DrugBank). Pharmacological intervention has traditionally focused on neutralizing the TNF ligand using monoclonal antibodies like Infliximab or soluble receptors like Etanercept. Emerging therapies are now targeting specific intracellular components of the complex, such as RIPK1 inhibitors (e.g., GSK2982772), to more precisely control the inflammatory response without inducing widespread cell death (ClinicalTrials.gov).

Other names

TNFRSF1A signaling complexTNF-R1 complexComplex IComplex IITNFR1-associated death domain complex

The primary mechanism involves the inhibition of TNF-alpha binding to TNFR1, preventing the assembly of the signaling complex. Other mechanisms include the inhibition of specific intracellular components like RIPK1 to block necroptosis and inflammation, or the use of Smac mimetics to degrade cIAPs, thereby sensitizing cells to TNF-induced apoptosis (Brenner et al., 2015; DrugBank).